For decades, cancer patients have been told that shrinking tumors meant accepting brutal side effects as the price of ...

Enhertu isn’t a typical chemotherapy or immunotherapy drug but rather a combination of chemotherapy and targeted therapy, known as an antibody-drug conjugate. Enhertu works by using an antibody to ...

In recent years, a drug called venetoclax has become a key part of treatment for AML. Approved in 2019, venetoclax is often ...

The chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as both heat-seeking missiles and Trojan horses for cancer cells, designed to specifically home in on a ...

Doxorubicin is a type of anthracycline chemotherapy drug used to treat certain types of solid tumors and blood cancers. It has a number of side effects, some more serious than others. Experts predict ...

Immunotherapy and targeted therapy — including PARP inhibitors and antibody-drug conjugates — can all be effective next steps for fighting breast cancer. Even though chemotherapy is the standard ...

An early-stage study has found that a common chemotherapy drug disrupts lymphatic cells in the tissue surrounding the brain. This is linked to memory issues in mice. When you purchase through links on ...

Various treatments are available for lymphoma, including chemotherapy, radiation, immunotherapy, targeted therapy, or a bone marrow transplant. A doctor or specialist can recommend which treatment is ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...